Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation

Blood

Volumn 98, Issue 13, 2001, Pages 3809-3816

  Deguillien, Mireille ^a,b,c   Huang, Shu Ching ^a,b,c   Morinière, Madeleine ^a,b,c   Dreumont, Natacha ^a,b,c   Benz Jr, Edward J ^a,b,c   Baklouti, Faouzi ^a,b,c  

^a UNIVERSITÉ LYON 1   (France)

^b Department of Medicine   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENINE; CYTOSINE; GUANINE; MESSENGER RNA PRECURSOR; NUCLEOTIDE; RNA; SPECTRIN; URACIL;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE; CONTROLLED STUDY; DNA FLANKING REGION; ENHANCER REGION; ERYTHROID CELL; ERYTHROLEUKEMIA; EXON; GENE SEQUENCE; INTRON; LEUKEMIA CELL; MEMBRANE BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; RNA SPLICING; SEQUENCE ANALYSIS; SPLICEOSOME;

EID: 0035895088     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.13.3809     Document Type: Article

References (47)

1. Bennett V, Gilligan DM. The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol. 1993;9:27-66.
2. Baklouti F, Huang SC, Vulliamy TJ, Delaunay J, Benz EJ Jr. Organization of the human protein 4.1 genomic locus: new insights into the tissuespecific alternative splicing of the pre-mRNA. Genomics. 1997;39:289-302.
3. Horne WC, Huang SC, Becker PS, Tang TK, Benz EJ Jr. Tissue-specific alternative spicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin. Blood. 1993;82:2558-2563.
4. Discher DE, Winardi R, Schischmanoff PO, Parra M, Conboy JG, Mohandas N. Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening. J Cell Biol. 1995;130:897-907.
5. Huang JP, Tang CJ, Kou GH, Marchesi VT, Benz EJ Jr, Tang TK. Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing. J Biol Chem. 1993;268:3758-3766.
6. Chasis JA, Coulombel L, Conboy J, et al. Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis. J Clin Invest. 1993;91:329-338.
7. Baklouti F, Huang SC, Tang TK, Delaunay J, Marchesi VT, Benz EJ Jr. Asynchronous regulation of splicing events within protein 4.1 premRNA during erythroid differentiation. Blood. 1996;87:3934-3941.
8. Lopez AJ. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu Rev Genet. 1998;32:279-305.
9. Smith CW, Valcarcel J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci. 2000;25:381-388.
10. Hastings ML, Krainer AR. Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol. 2001;13:302-309.
11. Graveley BR. Sorting out the complexity of SR protein functions. RNA. 2000;6:1197-1211.
12. Tang TK, Qin Z, Leto T, Marchesi VT, Benz EJ Jr. Heterogeneity of mRNA and protein products arising from the protein 4.1 gene in erythroid and nonerythroid tissues. J Cell Biol. 1990;110:617-624.
13. Maillet P, Delaunay J, Baklouti F. Chimeric probe-mediated ribonuclease protection assay for molecular diagnosis of mRNA deficiencies. Hum Mutat. 1996;7:61-64.
14. Morinière M, Ribeiro L, Dalla Venezia N, et al. Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure. Blood. 2000;95:1834-1841.
15. Tanaka K, Watakabe A, Shimura Y. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol. 1994;14:1347-1354.
16. Del Gatto-Konczak F, Olive M, Gesnel MC, Breathnach R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell Biol. 1999;19:251-260.
17. Reed R. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev. 1996;6:215-220.
18. Huh GS, Hynes RO. Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev. 1994;8:1561-1574.
19. Lim LP, Sharp PA. Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Mol Cell Biol. 1998;18:3900-3906.
20. Modafferi EF, Black DL. A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol. 1997;17:6537-6545.
21. Cramer P, Caceres JF, Cazalla D, et al. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell. 1999;4:251-258.
22. Baklouti F, Zhou J, Delaunay J, Huang SC, Benz EJ Jr. Characterization of cis-elements modulating alternative splicing of exons encoding the spectrin/actin binding domain in protein 4.1 pre-mRNA [abstract]. Blood. 1994;84(suppl 1):361a.
23. Stamm S, Zhang MQ, Marr TG, Heliman DM. A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res. 1994;22:1515-1526.
24. Chan RC, Black DL. Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro [published erratum appears in Mol Cell Biol 1997 May;17(5):2970]. Mol Cell Biol. 1995;15:6377-6385.
25. Gooding C, Roberts GC, Smith CW. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA. 1998;4:85-100.
26. Gee SL, Aoyagi K, Lersch R, Hou V, Wu M, Conboy JG. Alternative splicing of protein 4.1 R exon 16: ordered excision of flanking introns ensures proper splice site choice. Blood. 2000;95:692-699.
27. Chu ZL, Wickrema A, Krantz SB, Winkelmann JC. Erythroid-specific processing of human beta spectrin I pre-mRNA. Blood. 1994;84:1992-1999.
28. Orkin SH, Harosi FI, Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci U S A. 1975;72:98-102.
29. Dirksen WP, Hampson RK, Sun Q, Rottman FM. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem. 1994;269:6431-6436.
30. Eperon IC, Ireland DC, Smith RA, Mayeda A, Krainer AR. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J. 1993;12:3607-3617.
31. Zahler AM, Neugebauer KM, Lane WS, Roth MB. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 1993;260:219-222.
32. Gallego ME, Gattoni R, Stevenin J, Marie J, Expert-Bezancon A. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the betatropomyosin alternative exon 6A. EMBO J. 1997;16:1772-1784.
33. Carstens RP, McKeehan WL, Garcia-Blanco MA. An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol Cell Biol. 1998;18:2205-2217.
34. Cooper TA. Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol Cell Biol. 1998;18:4519-4525.
35. Kosaki A, Nelson J, Webster NJ. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J Biol Chem. 1998;273:10331-10337.
36. Markovtsov V, Nikolic JM, Goldman JA, Turck CW, Chou MY, Black DL. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol. 2000;20:7463-7479.
37. Reed R, Maniatis T. A role for exon sequences and splice-site proximity in splice-site selection. Cell. 1986;46:681-690.
38. Watakabe A, Tanaka K, Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 1993;7:407-418.
39. Tacke R, Manley JL. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 1995;14:3540-3551.
40. Si Z, Amendt BA, Stoltzfus CM. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res. 1997;25:861-867.
41. Caceres JF, Stamm S, Helfman DM, Krainer AR. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 1994;265:1706-1709.
42. Hou VC, Gee SL, Wu M, Turck CW, Mayeda A, Conboy JG. Developmentally-regulated expression of hnRNPA1 can regulate alternative splicing of protein 4.1R exon 16 through an interaction with an exonic splicing silencer [abstract]. Blood. 2000;96:441a.
43. Ashiya M, Grabowski PJ. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA. 1997;3:996-1015.
44. Huang SC, Baklouti F, Cheng H, Benz EJ Jr. Differential expression of the SR protein splicing factors and alternaiive splicing of protein 4.1 R exon 16 during erythroid maturation [abstract]. Blood. 2000;96:592a.
45. Chretien S, Dubart A, Beaupain D, et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci U S A. 1988;85:6-10.
46. Kaya AH, Plewinska M, Wong DM, Desnick RJ, Wetmur JG. Human delta-aminolevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. Genomics. 1994;19:242-248.
47. Aizencang GI, Bishop DF, Forrest D, Astrin KH, Desnick RJ. Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene. J Biol Chem. 2000;275:2295-2304.